Advertisement
Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Health-System Pharmacy, Vol. 63, Issue 3, 254-257
Copyright © 2006 by American Society of Health-System Pharmacists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nahata, M. C.
Right arrow Articles by Brady, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nahata, M. C.
Right arrow Articles by Brady, M. T.

Reports

Extemporaneous sildenafil citrate oral suspensions for the treatment of pulmonary hypertension in children

Milap C. Nahata, Richard S. Morosco and Michael T. Brady

MILAP C. NAHATA, M.S., PHARM.D., is Professor and Division Chair, College of Pharmacy, and Professor of Internal Medicine and Pediatrics, College of Medicine; RICHARD S. MOROSCO is Research Associate; and MICHAEL T. BRADY, M.D., is Professor of Pediatrics, College of Medicine, The Ohio State University, Columbus.

Address correspondence to Dr. Nahata at the College of Pharmacy, The Ohio State University, 500 West 12th Avenue, Columbus, OH 43210 (nahata.1{at}osu.edu).


Purpose. The stability of sildenafil citrate 2.5 mg/mL in two extemporaneously prepared oral suspensions stored at 4 and 25 °C was studied.

Methods. Thirty 25-mg tablets of sildenafil citrate were ground to powder, and the powder was combined with a 1:1 mixture of Ora-Sweet and Ora-Plus or a 1:1 mixture of methylcellulose 1% and Simple Syrup, NF, to produce two 2.5-mg/mL suspensions. Five plastic bottles of each suspension were stored in amber plastic prescription bottles at 4 or 25 °C. Samples were collected on days 0, 7, 14, 28, 42, 56, 70, and 91 for analysis of sildenafil content by high-performance liquid chromatography; pH was also measured. Samples were visually observed against black and white backgrounds.

Results. The mean concentration of sildenafil citrate exceeded 98% of the initial concentration in all samples at both temperatures throughout the 91-day study period. No changes in pH, odor, or physical appearance were observed.

Conclusion. Sildenafil citrate 2.5 mg/mL in two extemporaneously compounded oral suspensions was stable for 91 days in plastic prescription bottles at 4 and 25 °C.

Index terms: Compounding; Concentration; Hydrogen ion concentration; Hypertension; Methylcellulose; Odors; Ora-Plus; Ora-Sweet; Pediatrics; Sildenafil citrate; Stability; Storage; Sucrose; Suspending agents; Suspensions; Temperature; Vasodilating agents; Vehicles

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Society of Health-System Pharmacists.
Advertisement